Measures of atherosclerotic burden are associated with clinically manifest cardiovascular disease in type 2 diabetes: a European cross-sectional study.

Shore, Angela; Colhoun, H M; Natali, A; Palombo, C; Östling, G; Aizawa, Kunihiko; Kennbäck, C; Casanova, Francesco; Persson, M; Gooding, Kim M.; Gates, Phillip E.; Khan, F; Looker, H C; Adams, F; Belch, J; Pinnoli, S; Venturi, E; Morizzo, C; Goncalves, I; Ladenvall, C; Nilsson, J

URI

http://hdl.handle.net/11287/618056

Author

Shore, Angela

Colhoun, H M

Natali, A

Palombo, C

Östling, G

Aizawa, Kunihiko

Kennbäck, C

Casanova, Francesco

Persson, M

Gooding, Kim M.

Gates, Phillip E.

Khan, F

Looker, H C

Adams, F

Belch, J

Pinnoli, S

Venturi, E

Morizzo, C

Goncalves, I

Ladenvall, C

Nilsson, J

Date

2015-09

Journal

Journal of internal medicine

Type

Journal Article
Research Support, Non-U.S. Gov't

Publisher

Wiley

DOI

10.1111/joim.12359

Rights

Archived with thanks to Journal of internal medicine

Metadata

Show full item record

Abstract

There is a need to develop and validate surrogate markers of cardiovascular disease (CVD) in subjects with diabetes. The macrovascular changes associated with diabetes include aggravated atherosclerosis, increased arterial stiffness and endothelial dysfunction. The aim of this study was to determine which of these factors is most strongly associated with clinically manifest cardiovascular events.

Citation

Measures of atherosclerotic burden are associated with clinically manifest cardiovascular disease in type 2 diabetes: a European cross-sectional study. 2015, 278 (3):291-302 J. Intern. Med.

Publisher URL

http://dx.doi.org/10.1111/joim.12359